Portfolio Operations
Pubblicato il 12-08-2026 - Chiesi in Vicofertile
About usChiesi is an international research-focused biopharmaceutical group with 90 years’ experience, operating in more than 30 countries, with its Headquarter in Parma, Italy. More than 8,000 employees across the group are united by a singular purpose: promoting a healthier world for our people, patients, and the planet. This is what drives us as we research, develop, and market innovative drugs across our main therapeutic areas. Discover more here.At Chiesi we are thinking generations ahead, driving sustainable innovation with purpose. This fosters a culture of reliability, transparency, and ethical behaviour at every level. As a Vantaggi Corporation and a certified B Corp, we have embedded sustainability in our bylaws and continuously measure our impact.Diversity and inclusion are at the heart of who we are. We believe our differences make us stronger. We are a vibrant ecosystem of passionate, talented individuals united by strong values,
each bringing unique perspectives that help us to continuously challenge the status quo for the better.Who we are looking forThis is what you will doThe International Markets Development Division (IMDD) is responsible for expanding and managing Chiesi's operations in international markets. This division focuses on portfolio strategy, commercial excellence and the integration of various business units to enhance the company's presence and performance in growth and core markets.The Portfolio Operations & Launch Excellence Manager supports the Lifecycle Management & Launch Excellence function by providing operational, analytical, and governance support across Lifecycle Management, Launch Excellence, Geo-Expansion, and strategic business initiatives. The role will be responsible for driving execution follow-through, performance monitoring, KPI reporting, cross-functional coordination, and business analyses across priority markets.You will be responsible forStrategic Business Operations & Analytical SupportConsolidate LTP assumptions